Finasteride And Muscle Pain: What's The Link?

can finasteride cause muscle pain

Finasteride is a prescription drug used to treat hair loss and benign prostatic hyperplasia in men. It is also known by the brand names Proscar and Propecia. While generally considered safe and well-tolerated, finasteride has been associated with a range of side effects, including sexual dysfunction, skin reactions, and rarely, myopathy. There have also been reports of persistent muscle pain, weakness, atrophy, and spasms, suggesting a potential link between finasteride use and muscle-related side effects. Health Canada reviewed the risk of muscle-related side effects and concluded that while the risk could not be ruled out, there was insufficient evidence to confirm a causal relationship. This paragraph introduces the topic by providing an overview of finasteride's uses, potential side effects, and the ongoing debate surrounding its impact on muscle health.

Characteristics Values
Muscle-related side effects Rhabdomyolysis, myopathy, muscle pain, weakness, atrophy, stiffness, and spasms
Potential causes Specific mutations in isoenzyme genes, prolonged duration of drug usage, Post-Finasteride Syndrome (PFS)
Risk factors Age, dosage, and genetic makeup
Regulatory actions Health Canada recommended updating product information to include potential muscle-related risks; FDA demanded changes to package inserts in 2012

cyvigor

Finasteride may cause muscle pain, weakness, atrophy and spasms

Finasteride is a prescription drug used to treat hair loss and benign prostatic hyperplasia in men. It is also used to control non-cancerous enlargement of the prostate gland and improve related symptoms. Finasteride is associated with a range of side effects, and there is a possibility that it may cause muscle pain, weakness, atrophy, and spasms.

The World Health Organization's Adverse Drug Reaction Database recorded 508 reports of serious muscle-related side effects suspected to be linked to finasteride use. The reported side effects included muscle atrophy, weakness, myalgia (muscle pain), and sudden, strong muscle tightening (spasms). Health Canada reviewed the potential risk of serious muscle-related side effects with finasteride and concluded that it could not be ruled out. As a result, they recommended that manufacturers update the product information to include this potential risk.

Finasteride-induced myalgia has been documented in a case report of a 30-year-old man who developed diffuse muscle aches after taking finasteride for 10 years. His symptoms resolved, and his creatine kinase levels returned to normal within three weeks of discontinuing finasteride.

Post-Finasteride Syndrome (PFS) is a term used to describe persistent sexual, neuropsychiatric, and physical adverse reactions experienced by some patients who have used finasteride. Symptoms of PFS include muscle weakness, atrophy, pain, and spasms. The literature suggests that the effects of PFS can last for extended periods, and there is currently no known treatment.

It is important to note that while muscle-related side effects have been reported, studies have not conclusively confirmed a causal relationship between finasteride and these adverse effects. However, due to the potential risks, it is recommended to consult with a healthcare professional before taking finasteride and to report any experienced side effects.

cyvigor

Post-Finasteride Syndrome (PFS) includes persistent sexual, neuropsychiatric and physical adverse reactions

Finasteride is a prescription drug used to treat and control non-cancerous enlargement of the prostate gland and improve related symptoms. It is also used to treat hair loss in men at a lower dose. While it has been considered a safe and well-tolerated drug, recent reports have emerged of adverse reactions that persist for at least three months after discontinuation, leading to the coining of the term "Post-Finasteride Syndrome (PFS)".

PFS includes a range of persistent sexual, neuropsychiatric, and physical adverse reactions. Sexual side effects include decreased libido, erectile dysfunction, decreased ejaculated volume, infertility, loss of genital sensitivity, and decreased orgasmic sensation. Neuropsychiatric symptoms include depression, anxiety, suicidal ideation, panic attacks, emotional detachment, insomnia, memory problems, slow thinking, and comprehension difficulties. Physical symptoms include muscle weakness, muscle atrophy and/or pain, muscle spasms, joint pain, dry skin, penis shrinkage, abnormal penis curvature (Peyronie's disease), testicular pain, and testicular reduction.

The World Health Organization's Adverse Drug Reaction Database contained 508 reports of serious muscle-related side effects suspected of being linked to finasteride use, including atrophy, weakness, myalgia, and sudden, strong muscle tightening (spasms). However, there is insufficient evidence to confirm a causal relationship. Health Canada also reviewed the potential risk of serious muscle-related side effects and concluded that the risk could not be ruled out, recommending that manufacturers update product information to include this potential risk.

It is important to note that the literature on PFS is largely inconclusive, and studies to date cannot confirm or refute the existence of this syndrome. However, regulatory agencies in several countries have generated warnings about the potential risks associated with finasteride use. Clinicians should be vigilant when prescribing finasteride, especially to younger patients, and should inform patients about the possible side effects that may persist even after discontinuation of treatment.

Low Potassium: A Cause of Muscle Spasms?

You may want to see also

cyvigor

Finasteride is a 5α-reductase enzyme inhibitor that treats male androgenic alopecia

Finasteride is a prescription drug that is used to treat male androgenic alopecia, also known as male pattern baldness. It is a type 2 5α-reductase inhibitor, which means it blocks the enzyme that converts testosterone into a more potent form called dihydrotestosterone (DHT). DHT has been implicated as a contributing cause of androgenic alopecia, as it alters scalp hair follicles, leading to the production of miniaturised hair and a progressive decline in visible scalp hair density.

Clinical studies have shown that finasteride is effective in reducing scalp DHT levels and improving hair growth in men with androgenic alopecia. The optimal dose for treating this condition is 1 mg/day, and it has been shown to slow hair loss, increase hair growth, and improve the appearance of hair. Finasteride has also been found to be safe for use in men, with minimal adverse effects reported in clinical trials. However, some sexual side effects have been reported, including sexual dysfunction.

Finasteride was originally developed to treat benign prostatic hyperplasia (BPH) at a dose of 5 mg. However, it was subsequently evaluated as a treatment for androgenic alopecia at a lower dose. In Canada, finasteride at a dose of 5 mg is authorised for the treatment of BPH, while the 1 mg dose is authorised for treating hair loss in men.

While finasteride has been shown to be effective and relatively safe for treating androgenic alopecia, there have been some concerns about potential serious muscle-related side effects. Health Canada reviewed the risk of muscle-related adverse events due to reports from patients treated with Propecia and Proscar. The review concluded that the risk of serious muscle-related side effects with finasteride use could not be ruled out, and manufacturers have been recommended to update the product information to include this potential risk.

In summary, finasteride is a 5α-reductase enzyme inhibitor that has been proven effective and relatively safe for treating male androgenic alopecia at a dose of 1 mg/day. However, it is important to be aware of the potential risk of muscle-related side effects, and patients should report any adverse effects to their healthcare professionals.

cyvigor

Finasteride is a prescription drug that is authorised for sale in Canada to treat and control non-cancerous enlargement of the prostate gland in males. At a lower dose, it is also used to treat hair loss in men. Finasteride is an antiandrogen that inhibits type II 5-alpha reductase, an enzyme that converts testosterone to a more potent form, dihydrotestosterone (DHT). While finasteride has been considered a safe and well-tolerated drug, Health Canada reviewed the risk of potential serious muscle-related side effects due to reports of these events in patients treated with Propecia and Proscar.

The safety review focused on potential risks of adverse events such as rhabdomyolysis, myopathy, and other muscle disorders such as pain, weakness, atrophy, or stiffness. The World Health Organization's Adverse Drug Reaction Database contained 508 reports of serious muscle-related side effects suspected of being linked to finasteride use, including atrophy, weakness, myalgia, and muscle spasms. However, there was insufficient information to confirm a causal relationship.

Health Canada's review concluded that the risk of serious muscle-related side effects with finasteride use could not be ruled out. As a result, Health Canada recommended that manufacturers update the product information of finasteride-containing products to include this potential risk. Currently, the product information for finasteride does not mention the risk of muscle-related side effects. Health Canada encourages consumers and healthcare professionals to report any side effects associated with the use of this health product.

It is important to note that finasteride has been associated with other side effects, including sexual dysfunction, neuropsychiatric symptoms, and skin reactions. Regulatory agencies in several countries have issued warnings about the drug, and in 2015, Post-Finasteride Syndrome (PFS) was recognised as a rare genetic disease by the National Institutes of Health (NIH). PFS includes persistent sexual, neuropsychiatric, and physical adverse reactions, such as muscle weakness, atrophy, and pain. While studies have suggested potential permanent penile structural changes after the use of finasteride, more research is needed to establish causal relationships.

cyvigor

Finasteride may cause serious allergic and skin reactions

Finasteride is a prescription drug used to treat hair loss and benign prostatic hyperplasia in men. It is also used to control non-cancerous enlargement of the prostate gland and improve related symptoms. While it has been considered a safe and well-tolerated drug, there have been reports of adverse side effects, including serious allergic and skin reactions.

Finasteride can cause serious allergic and skin reactions, such as angioedema, Stevens-Johnson syndrome, and exfoliative dermatitis. It is important to be aware of the signs and symptoms of these reactions, which include blistering, peeling, or loosening of the skin, cracked, dry, or scaly skin, chills, cough, crusting, irritation, or reddening of the skin. Other possible symptoms include diarrhea, itching, large, hive-like swelling on the face, eyelids, lips, tongue, throat, hands, legs, feet, or genitals, joint or muscle pain, red irritated eyes, red skin lesions, sore throat, sores, ulcers, or white spots in the mouth or on the lips, swelling, or unusual tiredness or weakness. Women who are pregnant or may become pregnant should not use this medication as it can be absorbed through the skin and cause birth defects in male babies.

If you experience any of these symptoms, it is important to seek medical advice immediately. Finasteride has also been linked to post-finasteride syndrome (PFS), which includes persistent sexual, neuropsychiatric, and physical adverse reactions. Symptoms of PFS can include a decrease or complete loss of libido, low or no reaction to sexual stimulation, erectile dysfunction, loss of pleasure or sensation in orgasm, loss of genital sensitivity, decreased ejaculate volume, poor semen quality, infertility, penis shrinkage, abnormal penis curvature (Peyronie's disease), testicular pain, testicular reduction, gynecomastia, chronic fatigue, muscle weakness, muscle atrophy, and/or pain. While studies have reported these persistent symptoms, there is currently no known treatment for PFS.

The risk of serious muscle-related side effects with finasteride use has been investigated, with reports suggesting muscle pain, weakness, atrophy, and stiffness. The World Health Organization's Adverse Drug Reaction Database contained 508 reports of serious muscle-related side effects suspected of being linked to finasteride use. However, there was insufficient evidence to confirm a causal relationship. Health Canada has recommended that manufacturers update the product information to include this potential risk.

Frequently asked questions

Finasteride is a prescription drug used to treat hair loss and benign prostatic hyperplasia in men. It is also known as Proscar and is a 5α-reductase inhibitor, an antiandrogen that blocks the enzyme responsible for converting testosterone to Dihydrogentestosterone (DHT).

Finasteride has been associated with muscle-related side effects, including pain, weakness, atrophy, and stiffness. Health Canada reviewed the potential risks after reports of muscle issues in patients taking Propecia and Proscar. While the review could not conclude that Finasteride was the direct cause, it also could not rule out the possibility.

Finasteride may cause serious allergic and skin reactions, including angioedema, Stevens-Johnson syndrome, and exfoliative dermatitis. It can also lead to sexual dysfunction, neuropsychiatric issues, and persistent physical symptoms, collectively referred to as Post-Finasteride Syndrome (PFS).

If you experience muscle pain or any other side effects while taking Finasteride, consult your doctor or healthcare provider immediately. They will be able to advise you on the appropriate course of action and provide guidance based on your specific circumstances.

Written by
Reviewed by
Share this post
Print
Did this article help you?

Leave a comment